Recent studies suggest that the anti-tumour immune response can be orchestrated within these structures.5,6 Cytotoxic NK cells can also exert anti-tumour killing independently of any previous interaction with APCs,7 notably in the case of a loss of class I major histocompatibility complex (MHC) molecules on the surface of tumour cells. This evidence concerns the gene HLA-C and neoplasm.